Omrix Biopharmaceuticals
About:
Omrix Biopharmaceuticals develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.
Website: http://www.omrix.com
Top Investors: Hercules Capital, MPM Capital, Thuja Capital, Catalyst Fund LP
Description:
Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.
Total Funding Amount:
$26.5M
Headquarters Location:
Qiryat Ono, Tel Aviv, Israel
Founded Date:
1995-01-01
Contact Email:
webmaster(AT)ethus.jnj.com
Founders:
Robert Taub
Number of Employees:
501-1000
Last Funding Date:
2007-02-15
IPO Status:
Delisted
Industries:
© 2025 bioDAO.ai